Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bialactis Biotech is a Spanish biotechnology company specializing in the research, development, and commercialization of innovative probiotic strains and functional ingredients. Spun off from the University of Santiago de Compostela, the company focuses on improving human health through microbiome modulation, particularly in the areas of oral and digestive health. Their product portfolio includes clinically validated probiotic solutions designed to combat dental caries, periodontitis, and halitosis. Bialactis leverages advanced microbial screening and characterization technologies to identify high-performance strains for the pharmaceutical and food supplement industries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bialactis Biotech.